Dr. George is Professor of Psychiatry, and in the Institute of Medical Sciences (IMS) at the Temerty Faculty of Medicine, University of Toronto (UofT). He completed his undergraduate and medical school training at Dalhousie University, then completed psychiatry residency (1992-96) and fellowship in Translational Neuroscience (1996-98) at Yale School of Medicine in New Haven, Connecticut. He was on the Yale Psychiatry faculty from 1998-2007, and then moved to Toronto as the inaugural Chair in Addiction Psychiatry at UofT (2006-2012), and has served in several senior clinical and administrative positions at CAMH and in the Department of Psychiatry at UofT since 2008, including as Chief of the Schizophrenia (2008-16) and Addictions (2016-19) Divisions at CAMH.
Dr. George has over 300 peer-reviewed publications, reviews and other reports. Since 2013, he has been Deputy Editor of the journal of the American College of Neuropsychopharmacology (ACNP), Neuropsychopharmacology (NPP; 2020 Impact Factor 7.851). He has also written the chapter on Nicotine and Tobacco for Cecil Textbook of Medicine in 2011, 2015, 2019 and for the upcoming 2022 edition, and is the newly appointed Vice-Chair of the Scientific Advisory Committee of the Canadian Centre for Substance Use and Addiction (CCSA).
Areas of Research
Dr. George’s BACDRL Lab at CAMH focuses on understanding the biology of addiction co-morbidity in people with serious mental illness (e.g. schizophrenia, mood disorders, PTSD), and translating this knowledge towards novel and more effective treatment for concurrent disorders. His research program (BACDRL) is supported by the NIH/NIDA, CIHR and the CAMH Foundation.
View Dr. George's publications on PubMed.